Advertisement

Topics

Search Results for "Cancer Diagnostics"

18:24 EST 11th February 2016 | BioPortfolio

Matching Channels

Matching News

2015 Cancer Diagnostics Market: Test Volume and Sales Forecasts by Country

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of lab...

Amoy Diagnostics, Illumina Team Up to Discover Next-Gen Sequencing Cancer Diagnostics in China

Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer Diagnostics in China XIAMEN, China & SAN DIEGO--(BUSINESS WIRE)--Amoy Diagnostics Co. Ltd. (ADx) and I...

Amoy Diagnostics, Illumina Team Up to Discover Next-Gen Sequencing Cancer Diagnostics in China

Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer Diagnostics in China XIAMEN, China & SAN DIEGO--(BUSINESS WIRE)--Amoy Diagnostics Co. Ltd. (ADx) and I...

How Sienna Cancer Diagnostics are translating telomerase into a cancer biomarker.

Cliff Holloway, CEO to Sienna Cancer Diagnostics, discusses the development and commercialisation of SCE-A7, the first telomerase detection product.

Laying the Foundation for Next-Gen Cancer Diagnostics

Bio-IT World | This summer, Foundation Medicine will launch what could be described as the next generation of cancer diagnostics. The Cambridge, Mass.-based company, founded by a premier group of can...

Illumina join hands with Amoy Diagnostics

Biospectrum Amoy Diagnostics and Illumina enter strategic collaboration for Next-Generation Sequencing cancer diagnosti...

EKF's PointMan Used In Successful Liquid Biopsy Research

EKF Diagnostics, the global in vitro diagnostics company, announces that results from a study involving EKF Molecular’s PointMan DNA enrichment technology have been published in Clinical Cancer ...

Molecular imaging technologies for cancer diagnostics Hangout: Cancer Immunotherapy Growing

by John Bennett MD We hosted a hangout with Shahriar Yaghoubi, Ph.D., MBA. Dr Yaghoubi has been doing pre-clinical and clinical research for over 20 years, now holding a position as CSO/Director of C...

Matching PubMed Articles

Drug sensitivity testing platforms for gastric cancer diagnostics.

Gastric cancer diagnostics has traditionally been histomorphological and primarily the domain of surgical pathologists. Although there is an increasing usage of molecular and genomic techniques for cl...

Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer.

Companion diagnostics (CDx) have become a major tool in molecular pathology and assist in therapy decisions in an increasing number of various cancers. Particularly, the developments in lung cancer ha...

Companion diagnostics for the targeted therapy of gastric cancer.

Gastric cancer is the fourth most common type of cancer and represents a major cause of cancer-related deaths worldwide. With recent biomedical advances in our understanding of the molecular character...

Activin A as a novel biomarker for colorectal adenocarcinoma in humans.

Early diagnostics of colorectal cancer is complicated by the lack of reliable serum biomarkers. This study aimed to investigate if the serum level of activin A can be used for diagnostics of this dise...

Development of Companion Diagnostics.

The goal of individualized and targeted treatment and precision medicine requires the assessment of potential therapeutic targets to direct treatment selection. The biomarkers used to direct precision...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement